azathioprine has been researched along with Cholangitis, Sclerosing in 46 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Cholangitis, Sclerosing: Chronic inflammatory disease of the BILIARY TRACT. It is characterized by fibrosis and hardening of the intrahepatic and extrahepatic biliary ductal systems leading to bile duct strictures, CHOLESTASIS, and eventual BILIARY CIRRHOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with primary sclerosing cholangitis (PSC) are at increased risk for developing cholangiocarcinoma (CCA)." | 5.43 | No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis. ( Boberg, KM; Bubenheim, M; Ehlken, H; Hartl, J; Hübener, P; Hübener, S; Jørgensen, KK; Karlsen, TH; Lenzen, H; Lohse, AW; Manns, MP; Pannicke, N; Peiseler, M; Schramm, C; Schulze, K; Sebode, M; Weiler-Normann, C; Weismüller, TJ; Zenouzi, R, 2016) |
| "In up to 80% of cases primary sclerosing cholangitis (PSC) is associated with inflammatory bowel diseases (IBD)." | 5.39 | Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine. ( Astegiano, M; Bonagura, AG; Cisarò, F; Pallavicino, F; Pellicano, R; Reggiani, S; Rizzetto, M; Sguazzini, C; Simondi, D, 2013) |
| "Treatment of primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) with ursodeoxycholic acid (UDCA) has been in common use since 1985." | 4.81 | Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis. ( Holtmeier, J; Leuschner, U, 2001) |
| "MODE OF ACTION OF URSODEOXYCHOLIC ACID: In cholestasis, the impaired biliary secretion of toxic bile acids causes their accumulation in the liver and a subsequent hepatic failure." | 4.81 | [Treatment of cholestatic liver diseases]. ( Gatzen, M; Pausch, J, 2002) |
| " For primary biliary cirrhosis, ursodeoxycholic acid is safe and is the first choice for treatment." | 3.74 | Guidelines for therapy of autoimmune liver disease. ( Gershwin, ME; Ishibashi, H; Komori, A; Shimoda, S, 2007) |
| "The risk of acute pancreatitis in patients with IBD is increased due to the higher incidence of cholelithiasis and drug-induced pancreatitis in this population." | 2.82 | Pancreatic Disorders in Patients with Inflammatory Bowel Disease. ( Bi, Y; Corral, JE; Farraye, FA; Ji, B; Kröner, PT; Lukens, FJ; Montenegro, ML, 2022) |
| "Autoimmune liver diseases (autoimmune hepatitis, primary sclerosing cholangitis, overlap syndrome) can occur in the setting of limited symptoms; therefore, a high index of suspicion and appropriate diagnostic workup should be performed." | 2.72 | Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis. ( Kemme, S; Mack, CL, 2021) |
| "An increased risk of colorectal cancer (CRC) is present also after LT in IBD patients with primary sclerosing cholangitis (PSC)." | 2.50 | Clinical management of inflammatory bowel disease in the organ recipient. ( Indriolo, A; Ravelli, P, 2014) |
| "A higher risk of colorectal cancer has been described among ulcerative colitis patients with primary sclerosing cholangitis." | 2.49 | Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature. ( Chaparro, M; Gisbert, JP; Guijarro, M; López, C; Moreno-Otero, R; Trapero-Marugán, M, 2013) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC) and overlap syndromes of these three disease entities are regarded as autoimmune liver diseases." | 2.42 | [Autoimmune liver disease: diagnosis and therapy]. ( Bayer, EM; Kanzler, S; Lohse, AW; Schramm, C, 2004) |
| "Autoimmune Hepatitis (AIH), primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) represent acute and chronic inflammatory liver diseases in which immune reactions against host antigens are found to be the major pathological mechanism." | 2.41 | [Autoimmune hepatitis and overlap syndrome: therapy]. ( Löhr, HF, 2002) |
| "A case of autoimmune hepatitis (AIH) complicated by primary sclerosing cholangitis (PSC) in a 36-year-old woman is reported." | 2.41 | Autoimmune hepatitis overlapping with primary sclerosing cholangitis. ( Funabashi, Y; Kasukawa, R; Kumakawa, H; Ohira, H; Rai, T; Sato, Y; Shishido, S; Takiguchi, J; Tojo, J; Watanabe, H, 2002) |
| "The diagnosis and management of autoimmune hepatitis continues to evolve as new diagnostic tests and new therapies are added to the armamentarium." | 2.41 | Autoimmune liver disease. Current standards, future directions. ( Gish, RG; Mason, A, 2001) |
| "Cyclosporine (CSA) is an alternative treatment for autoimmune hepatitis (AIH), however, its unknown long-term safety and efficacy have limited its use." | 1.51 | Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine. ( Cirillo, F; Maggiore, G; Malaventura, C; Matarazzo, L; Nastasio, S; Riva, S; Sciveres, M, 2019) |
| "Primary sclerosing cholangitis (PSC) is a liver disease that leads to progressive destruction and stricturing of the biliary tree." | 1.46 | Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation. ( Gow, P; Hey, P; Johnson, P; Lokan, J, 2017) |
| " Tacrolimus dosage was 2 mg/day (median)." | 1.43 | Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy. ( Adams, DH; Füssel, K; Hirschfield, GM; Hodson, J; Lohse, AW; Mann, J; Oo, YH; Schramm, C; Than, NN; Weiler-Normann, C; Wiegard, C, 2016) |
| "Patients with primary sclerosing cholangitis (PSC) are at increased risk for developing cholangiocarcinoma (CCA)." | 1.43 | No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis. ( Boberg, KM; Bubenheim, M; Ehlken, H; Hartl, J; Hübener, P; Hübener, S; Jørgensen, KK; Karlsen, TH; Lenzen, H; Lohse, AW; Manns, MP; Pannicke, N; Peiseler, M; Schramm, C; Schulze, K; Sebode, M; Weiler-Normann, C; Weismüller, TJ; Zenouzi, R, 2016) |
| "Retrospective review of AILD [autoimmune hepatitis type 1 and 2 (AIH1, AIH2), primary sclerosing cholangitis (PSC) and autoimmune sclerosing cholangitis (ASC)] seen at two pediatric liver units in Malaysia." | 1.42 | Characteristics and outcome of autoimmune liver disease in Asian children. ( Boey, CC; Chong, SY; Khoh, KM; Lee, WS; Lim, CB; Lum, SH; Ng, RT; Pailoor, J; Teo, KM, 2015) |
| "Overlap syndrome of autoimmune hepatitis (AIH) and primary sclerosing cholangitis (PSC) is considered when the patient presents with the diagnostic criteria of both diseases at some stage of the medical history, either simultaneously or consecutively." | 1.39 | Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy. ( Bahri, I; Boudawara, T; Gargouri, L; Maalej, B; Mahfoudh, A; Majdoub, I; Mnif, H; Mnif, L; Safi, F; Tahri, N; Turki, F, 2013) |
| "In up to 80% of cases primary sclerosing cholangitis (PSC) is associated with inflammatory bowel diseases (IBD)." | 1.39 | Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine. ( Astegiano, M; Bonagura, AG; Cisarò, F; Pallavicino, F; Pellicano, R; Reggiani, S; Rizzetto, M; Sguazzini, C; Simondi, D, 2013) |
| "Crohn's disease is rare in South African black people and primary sclerosing cholangitis (PSC) is also rare in black patients with IBD, from South Africa." | 1.38 | Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women. ( Bezuidenhout, E; Bosch, FJ; Buchel, OC; de K Grundling, H; de Vries, CS; Fevery, J; Janse van Rensburg, J; Middlecote, BD; van Zyl, JH, 2012) |
| "Ulcerative colitis (UC) associated with primary sclerosing cholangitis (PSC) is usually clinically mild." | 1.37 | Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis? ( Burroughs, AK; Cholongitas, E; Hamilton, MI; Kalambokis, G; Marelli, L; Xirouchakis, E, 2011) |
| "We also compare this atypical sclerosing cholangitis (group I) to typical sclerosing cholangitis (group II) and to autoimmune hepatitis with (group III) and without (group IV) cholestasis." | 1.30 | An atypical presentation for primary sclerosing cholangitis. ( Gomez, DA; Luketic, VA; Sanyal, AJ; Shiffman, ML, 1997) |
| " There was no increase in concurrent immunosuppressives dosage after the conversion." | 1.29 | Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation. ( Kaplan, MM; Pedrosa, MC; Rohrer, RM, 1995) |
| "We report a 36-year-old man with Crohn's disease, primary sclerosing cholangitis, and alopecia universalis." | 1.29 | Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease. ( Jakob, F; Klein, R; Seibold, F, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.17) | 18.7374 |
| 1990's | 6 (13.04) | 18.2507 |
| 2000's | 14 (30.43) | 29.6817 |
| 2010's | 19 (41.30) | 24.3611 |
| 2020's | 6 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Kemme, S | 1 |
| Mack, CL | 1 |
| Han, IS | 1 |
| Baek, DH | 1 |
| Hong, SM | 1 |
| Lee, BE | 1 |
| Lee, MW | 1 |
| Kim, GH | 1 |
| Song, GA | 1 |
| Yassin, S | 1 |
| De Lacy, R | 1 |
| Pillay, K | 1 |
| Goddard, E | 1 |
| Creutzfeldt, AM | 1 |
| Piecha, F | 1 |
| Schattenberg, JM | 1 |
| Schramm, C | 6 |
| Lohse, AW | 6 |
| Peverelle, M | 1 |
| De Cruz, P | 1 |
| Paleri, S | 1 |
| Gow, PJ | 1 |
| Montenegro, ML | 1 |
| Corral, JE | 1 |
| Lukens, FJ | 1 |
| Ji, B | 1 |
| Kröner, PT | 1 |
| Farraye, FA | 1 |
| Bi, Y | 1 |
| Yang, X | 1 |
| Xu, H | 1 |
| Yang, J | 1 |
| Yang, L | 1 |
| Hey, P | 1 |
| Lokan, J | 1 |
| Johnson, P | 1 |
| Gow, P | 1 |
| Sokollik, C | 1 |
| McLin, VA | 1 |
| Vergani, D | 2 |
| Terziroli Beretta-Piccoli, B | 1 |
| Mieli-Vergani, G | 2 |
| Stokkeland, K | 1 |
| Höijer, J | 1 |
| Bottai, M | 1 |
| Söderberg-Löfdal, K | 1 |
| Bergquist, A | 1 |
| Nastasio, S | 1 |
| Sciveres, M | 1 |
| Matarazzo, L | 1 |
| Malaventura, C | 1 |
| Cirillo, F | 1 |
| Riva, S | 1 |
| Maggiore, G | 1 |
| Di Giorgio, A | 1 |
| D'Adda, A | 1 |
| Marseglia, A | 1 |
| Sonzogni, A | 1 |
| Licini, L | 1 |
| Nicastro, E | 1 |
| D'Antiga, L | 1 |
| Buchel, OC | 1 |
| Bosch, FJ | 1 |
| Janse van Rensburg, J | 1 |
| Bezuidenhout, E | 1 |
| de Vries, CS | 1 |
| van Zyl, JH | 1 |
| Middlecote, BD | 1 |
| de K Grundling, H | 1 |
| Fevery, J | 1 |
| Gargouri, L | 1 |
| Mnif, L | 1 |
| Safi, F | 1 |
| Turki, F | 1 |
| Majdoub, I | 1 |
| Maalej, B | 1 |
| Bahri, I | 1 |
| Mnif, H | 1 |
| Boudawara, T | 1 |
| Tahri, N | 1 |
| Mahfoudh, A | 1 |
| Indriolo, A | 1 |
| Ravelli, P | 1 |
| Vo, HD | 1 |
| Xu, J | 1 |
| Rabinowitz, SS | 1 |
| Fisher, SE | 1 |
| Schwarz, SM | 1 |
| Lee, WS | 1 |
| Lum, SH | 1 |
| Lim, CB | 1 |
| Chong, SY | 1 |
| Khoh, KM | 1 |
| Ng, RT | 1 |
| Teo, KM | 1 |
| Boey, CC | 1 |
| Pailoor, J | 1 |
| Than, NN | 1 |
| Wiegard, C | 1 |
| Weiler-Normann, C | 2 |
| Füssel, K | 1 |
| Mann, J | 1 |
| Hodson, J | 1 |
| Hirschfield, GM | 1 |
| Adams, DH | 1 |
| Oo, YH | 1 |
| Rodrigues, AT | 1 |
| Liu, PM | 1 |
| Fagundes, ED | 1 |
| Queiroz, TC | 1 |
| de Souza Haueisen Barbosa, P | 1 |
| Silva, SL | 1 |
| Simões E Silva, AC | 1 |
| Miranda, DM | 1 |
| Ferreira, AR | 1 |
| Alberti, LR | 1 |
| Zenouzi, R | 1 |
| Weismüller, TJ | 1 |
| Jørgensen, KK | 1 |
| Bubenheim, M | 1 |
| Lenzen, H | 1 |
| Hübener, P | 1 |
| Schulze, K | 1 |
| Sebode, M | 1 |
| Ehlken, H | 1 |
| Pannicke, N | 1 |
| Hartl, J | 1 |
| Peiseler, M | 1 |
| Hübener, S | 1 |
| Karlsen, TH | 1 |
| Boberg, KM | 1 |
| Manns, MP | 1 |
| Krok, KL | 1 |
| Munoz, SJ | 1 |
| Wellge, BE | 1 |
| Sterneck, M | 1 |
| Teufel, A | 1 |
| Rust, C | 1 |
| Franke, A | 1 |
| Schreiber, S | 1 |
| Berg, T | 1 |
| Günther, R | 1 |
| Kreisel, W | 1 |
| Zu Eulenburg, C | 1 |
| Braun, F | 1 |
| Beuers, U | 1 |
| Galle, PR | 1 |
| Marelli, L | 1 |
| Xirouchakis, E | 1 |
| Kalambokis, G | 1 |
| Cholongitas, E | 1 |
| Hamilton, MI | 1 |
| Burroughs, AK | 1 |
| Finsterer, J | 1 |
| Höflich, S | 1 |
| Chaparro, M | 1 |
| Trapero-Marugán, M | 1 |
| Guijarro, M | 1 |
| López, C | 1 |
| Moreno-Otero, R | 1 |
| Gisbert, JP | 1 |
| Pallavicino, F | 1 |
| Pellicano, R | 1 |
| Reggiani, S | 1 |
| Simondi, D | 1 |
| Sguazzini, C | 1 |
| Bonagura, AG | 1 |
| Cisarò, F | 1 |
| Rizzetto, M | 1 |
| Astegiano, M | 1 |
| Löhr, HF | 1 |
| Takiguchi, J | 1 |
| Ohira, H | 1 |
| Rai, T | 1 |
| Shishido, S | 1 |
| Tojo, J | 1 |
| Sato, Y | 1 |
| Kasukawa, R | 1 |
| Watanabe, H | 1 |
| Funabashi, Y | 1 |
| Kumakawa, H | 1 |
| Bayer, EM | 1 |
| Kanzler, S | 1 |
| Vetter, C | 1 |
| Maier, KP | 1 |
| Strassburg, CP | 1 |
| Ishibashi, H | 1 |
| Komori, A | 1 |
| Shimoda, S | 1 |
| Gershwin, ME | 1 |
| Pedrosa, MC | 1 |
| Rohrer, RM | 1 |
| Kaplan, MM | 3 |
| Stephens, J | 1 |
| Goldstein, R | 1 |
| Crippin, J | 1 |
| Husberg, B | 1 |
| Holman, M | 1 |
| Gonwa, TA | 1 |
| Klintmalm, G | 1 |
| Seibold, F | 1 |
| Klein, R | 1 |
| Jakob, F | 1 |
| Luketic, VA | 1 |
| Gomez, DA | 1 |
| Sanyal, AJ | 1 |
| Shiffman, ML | 1 |
| Schirmacher, P | 1 |
| Helmreich-Becker, I | 1 |
| Gerken, G | 1 |
| zum Büschenfelde, KH | 1 |
| Angulo, P | 1 |
| Lindor, KD | 1 |
| Gish, RG | 1 |
| Mason, A | 1 |
| Holtmeier, J | 1 |
| Leuschner, U | 1 |
| Gatzen, M | 1 |
| Pausch, J | 1 |
| Broomé, U | 1 |
| Glaumann, H | 1 |
| Lindstöm, E | 1 |
| Lööf, L | 1 |
| Almer, S | 1 |
| Prytz, H | 1 |
| Sandberg-Gertzén, H | 1 |
| Lindgren, S | 1 |
| Fork, FT | 1 |
| Järnerot, G | 1 |
| Olsson, R | 1 |
16 reviews available for azathioprine and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Pediatric Autoimmune Liver Diseases: Autoimmune Hepatitis and Primary Sclerosing Cholangitis.
Topics: Adolescent; Asymptomatic Diseases; Autoimmune Diseases; Azathioprine; Biomarkers; Child; Cholangitis | 2021 |
Pancreatic Disorders in Patients with Inflammatory Bowel Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Pancreatitis; Azathioprin | 2022 |
Juvenile autoimmune hepatitis: A comprehensive review.
Topics: Adolescent; Adult; Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Disease Management; | 2018 |
Clinical management of inflammatory bowel disease in the organ recipient.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colorectal Neoplasms; End Stage Liver Disease; Gra | 2014 |
The liver in pediatric gastrointestinal disease.
Topics: Adolescent; Antibodies, Monoclonal; Azathioprine; Celiac Disease; Chemical and Drug Induced Liver In | 2014 |
Dysplasia and colorectal cancer in a patient with ulcerative colitis and primary sclerosing cholangitis: a case report and a short review of the literature.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Cholangitis, S | 2013 |
[Autoimmune hepatitis and overlap syndrome: therapy].
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Haplotypes; Hepatitis, Autoimmune; | 2002 |
Autoimmune hepatitis overlapping with primary sclerosing cholangitis.
Topics: Adult; Autoantibodies; Azathioprine; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, S | 2002 |
Autoimmune hepatitis in children.
Topics: Autoantibodies; Azathioprine; Child; Cholangitis, Sclerosing; Female; Hepatitis, Autoimmune; HLA-DR3 | 2002 |
[Autoimmune liver disease: diagnosis and therapy].
Topics: Adult; Autoantibodies; Autoimmune Diseases; Azathioprine; Biopsy; Child; Cholagogues and Choleretics | 2004 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
[Autoimmune liver diseases and their overlap syndromes].
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Autoantibodies; Autoimmune Diseases; Azath | 2006 |
Autoimmune liver disease. Current standards, future directions.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Cholagogues and Choleretics; Cholangiti | 2001 |
Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.
Topics: Azathioprine; Celiac Disease; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Co | 2001 |
[Treatment of cholestatic liver diseases].
Topics: Adult; Age Factors; Anti-Inflammatory Agents; Azathioprine; Bile; Child; Cholagogues and Choleretics | 2002 |
Medical approaches to primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antipruritics; Azathioprine; Cholangitis, Sclerosing | 1991 |
30 other studies available for azathioprine and Cholangitis, Sclerosing
| Article | Year |
|---|---|
Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis.
Topics: Azathioprine; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Humans; Incidence | 2023 |
Characteristics and Outcomes of Autoimmune Hepatitis from a Tertiary Paediatric Centre, Cape Town, South Africa.
Topics: Autoantibodies; Azathioprine; Biopsy; Child; Child, Preschool; Cholangiopancreatography, Magnetic Re | 2020 |
Long-term outcome in PSC patients receiving azathioprine: Does immunosuppression have a positive effect on survival?
Topics: Adult; Azathioprine; Bile Ducts; Cholangiocarcinoma; Cholangitis, Sclerosing; Disease Progression; F | 2020 |
Impact of Inflammatory Bowel Disease and Azathioprine on Long-Term Outcomes After Liver Transplantation for Primary Sclerosing Cholangitis.
Topics: Azathioprine; Cholangitis, Sclerosing; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases | 2021 |
Rare gene variants in a patient with azathioprine-induced lethal myelosuppression.
Topics: Azathioprine; Bone Marrow Diseases; Cholangitis, Sclerosing; Ethnicity; Genetic Predisposition to Di | 2017 |
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantation.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Cholangitis, Sclerosing; Ciprofloxacin; Drug Therapy, Co | 2017 |
Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Cholangit | 2019 |
Long-term follow-up of children and young adults with autoimmune hepatitis treated with cyclosporine.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis, Sclerosing; Cyclosporine; Drug Thera | 2019 |
Biliary features in liver histology of children with autoimmune liver disease.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cholangitis; Cholangitis, Sclerosing; Drug Therap | 2019 |
Primary sclerosing cholangitis, Crohn's disease and HLA-B27 in black South African women.
Topics: Adult; Alkaline Phosphatase; Azathioprine; Back Pain; Black People; Cholagogues and Choleretics; Cho | 2012 |
Type 2 autoimmune hepatitis overlapping with primary sclerosing cholangitis in a 10-year-old boy.
Topics: Alkaline Phosphatase; Azathioprine; Biomarkers; Child; Cholagogues and Choleretics; Cholangitis, Scl | 2013 |
Characteristics and outcome of autoimmune liver disease in Asian children.
Topics: Adolescent; Anti-Inflammatory Agents; Asian People; Azathioprine; Child; Child, Preschool; Cholangit | 2015 |
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Aspartate Aminotransferases; Azathioprine; Cholan | 2016 |
Clinical Characteristics and Prognosis in Children and Adolescents With Autoimmune Hepatitis and Overlap Syndrome.
Topics: Adolescent; Azathioprine; Brazil; Child; Child Health Services; Cholangitis, Sclerosing; Cohort Stud | 2016 |
No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis.
Topics: Adult; Azathioprine; Cholangiocarcinoma; Cholangitis, Sclerosing; Female; Germany; Humans; Immunosup | 2016 |
Management of autoimmune and cholestatic liver disorders.
Topics: Anti-Inflammatory Agents; Azathioprine; Carcinoma, Hepatocellular; Cholagogues and Choleretics; Chol | 2009 |
Pregnancy in primary sclerosing cholangitis.
Topics: Adolescent; Adult; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Female; Follo | 2011 |
Does the severity of primary sclerosing cholangitis influence the clinical course of associated ulcerative colitis?
Topics: Adult; Aged; Azathioprine; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Colonic Neoplasm | 2011 |
Long-term, low-dose immunosuppression for myasthenia does not affect collateral, asymptomatic sclerosing cholangitis.
Topics: Aged; Asymptomatic Diseases; Azathioprine; Cholangitis, Sclerosing; Female; Humans; Immunosuppressio | 2012 |
Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine.
Topics: Adolescent; Adult; Azathioprine; Child; Cholangitis, Sclerosing; Female; Humans; Inflammatory Bowel | 2013 |
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; | 2005 |
Guidelines for therapy of autoimmune liver disease.
Topics: Animals; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Glucocorticoids; Hepati | 2007 |
Alternate-day prednisone in the maintenance immunosuppressive therapy after orthotopic liver transplantation.
Topics: Adolescent; Adult; Aged; Azathioprine; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Cholangiocarc | 1995 |
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients.
Topics: Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Crohn Disease; Cyclophosphamide; Cyclosp | 1993 |
Polymyositis, alopecia universalis, and primary sclerosing cholangitis in a patient with Crohn's disease.
Topics: Adult; Alopecia; Anti-Inflammatory Agents; Antigens, CD; Azathioprine; Cholangiopancreatography, End | 1996 |
An atypical presentation for primary sclerosing cholangitis.
Topics: Adrenal Cortex Hormones; Adult; Autoimmune Diseases; Azathioprine; Cholangiography; Cholangitis, Scl | 1997 |
Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.
Topics: Adult; Azathioprine; Cholagogues and Choleretics; Cholangitis, Sclerosing; Drug Therapy, Combination | 1999 |
Medical treatment for primary sclerosing cholangitis: risk versus benefit.
Topics: Azathioprine; Cholangitis, Sclerosing; Drug Therapy, Combination; Humans; Prednisolone; Ursodeoxycho | 2000 |
Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC).
Topics: Adolescent; Adult; Aged; Antimetabolites; Azathioprine; Bile Duct Neoplasms; Bile Ducts, Extrahepati | 2002 |
Chronic liver diseases: current therapeutic options.
Topics: Adrenal Cortex Hormones; Autoimmune Diseases; Azathioprine; Cholangitis, Sclerosing; Chronic Disease | 1989 |